Apontis Pharma AG | APPH Logo | Annual Report & Investor Relations Data

Apontis Pharma AG | APPH - Annual Report & Investor Relations Data

Apontis Pharma AG | APPH
Annual Report & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Ticker

APPH

Sector

Health Care

Industry

Biotechnology

Country

Germany

Year Founded

1946

Apontis Pharma AG (APPH)

About Apontis Pharma AG

APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single Pills combine two to three generic active ingredients in one combination preparation. APONTIS PHARMA develops, markets and distributes a broad portfolio of Single Pills and other medicines, with a particular focus on cardiovascular diseases. Since 2013, APONTIS has successfully launched several Single Pills solely for cardiovascular indications such as hypertension, hyperlipidaemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in the heart of Europe's strongest pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a target customer group of around 23,000 doctors in Germany.

Employees

168

Market Presence

Germany

Headquarters

Alfred-Nobel-Straße 10
40789, Monheim am Rhein
Germany

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Apontis Pharma AG (APPH)
Filings & Annual Reports

Filters

View all types
Filing Information Actions

Insider Trading Activity

Person (Position) Type Volume Price Date
Milz, Thomas (Board)
Buy EUR 8,960.00 EUR 8.96 14.05.24
be executive GmbH (Close relation)
Buy EUR 8,880.00 EUR 8.88 14.05.24
Zimmermann, Thomas (Other)
Buy EUR 10,128.00 EUR 8.44 13.05.24
Zimmermann, Thomas (Other)
Buy EUR 3,396.00 EUR 8.49 13.05.24
Zimmermann, Thomas (Other)
Buy EUR 1,692.00 EUR 8.46 13.05.24
Zimmermann, Thomas (Other)
Buy EUR 1,688.00 EUR 8.44 13.05.24
Reineke, Silke (Close relation)
Buy EUR 36,625.00 EUR 7.33 05.05.23
Milz, Thomas (Board)
Buy EUR 14,360.00 EUR 7.18 05.05.23

Apontis Pharma AG (APPH)
Stock & Investor Information

ISINs

DE000A3CMGM5
DE000A40KY75

LEI

894500ETO1J6MR8PDF91

Designated Sponsor

Hauck Aufhäuser Lampe Privatbank AG

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Apontis Pharma AG (APPH)
Related Companies & Peer Group

1NKEMIA Logo

1NKEMIA

IKM

Sector

Health Care

Country

Spain

ISIN

Founded

1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.

2cureX AB Logo

2cureX AB

2CUREX

Sector

Health Care

Country

Sweden

ISIN

SE0010468124

Founded

2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

Abera Bioscience AB Logo

Abera Bioscience AB

ABERA

Sector

Health Care

Country

Sweden

ISIN

SE0015245097

Founded

Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …